Sona Nanotech Equity 2024

Sona Nanotech Aktienanalyse

What does Sona Nanotech do?

Sona Nanotech Inc. is an innovative company specializing in the development and commercialization of highly specific, ultrasensitive diagnostic tests for the medical sector. The Canadian company, headquartered in Halifax, was founded in 2012 and has since become a global leader in nanoparticle diagnostics. The idea for the establishment of Sona Nanotech was based on the research of founders Dr. Gerrard Marangoni and Dr. Kulbir Singh. The two scientists worked at Dalhousie University in Nova Scotia and developed a novel technology to detect specific target molecules in blood or urine. This technology is based on the use of gold nanoparticles coated with specific antibodies or aptamers. The purpose of these nanoparticles is to detect specific molecules in blood or urine and confirm their presence or absence as a result of analysis. Sona Nanotech's business model involves the development, manufacturing, and distribution of these nanoparticles. The company offers a wide range of diagnostic test services, with a focus on developing specific tests for various diseases. To this end, Sona Nanotech has established its own research and development department, which works closely with clinics, hospitals, and government agencies to better understand and respond to the needs of the medical community. Sona Nanotech is divided into several business areas. The main area is the sale of diagnostic tests, such as Covid-19 rapid tests, for the medical sector. These tests have been developed to detect the presence of viral particles in blood or urine. Sona Nanotech also offers specific tests for other diseases such as cancer or HIV. In addition to these standard tests, the company also offers customized solutions for the medical sector. Another business field of Sona Nanotech is research and development in the field of nanoparticle diagnostics. The company heavily invests in the advancement of its technology and continuously works on new applications for its nanoparticles. This also includes collaboration with scientific institutions and partners in the field of nanotechnology. In recent years, Sona Nanotech has significantly expanded its presence in the global market. The company works with partners around the world and operates its own branches in the United States and Europe. The product range has also been expanded: In addition to diagnostic tests, the company also offers various products based on its nanoparticle technology. This includes special color markers for the detection of viruses and bacteria, as well as products for environmental monitoring and food safety. Sona Nanotech has quickly become one of the leading companies in the field of nanoparticle diagnostics. The company is proud to actively contribute to improving medical care and saving lives. By continuing research and development in the field of nanoparticles, the company hopes to develop new and innovative solutions for the medical sector in the future. Sona Nanotech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Sona Nanotech's Equity

Sona Nanotech's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Sona Nanotech's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Sona Nanotech's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Sona Nanotech's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Sona Nanotech’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Sona Nanotech stock

What is the equity of Sona Nanotech this year?

Sona Nanotech has equity of 1.16 M CAD this year.

What was the equity of Sona Nanotech compared to the previous year?

The equity of Sona Nanotech has increased/decreased by -328.8% decreased compared to the previous year.

What impact does a high equity have on investors of Sona Nanotech?

A high equity is advantageous for investors of Sona Nanotech as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Sona Nanotech?

A low equity can be a risk for investors of Sona Nanotech, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Sona Nanotech affect the company?

An increase in equity of Sona Nanotech can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Sona Nanotech affect the company?

A reduction in equity of Sona Nanotech can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Sona Nanotech?

Some factors that can affect the equity of Sona Nanotech include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Sona Nanotech so important for investors?

The equity of Sona Nanotech is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Sona Nanotech take to change the equity?

To change equity, Sona Nanotech can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Sona Nanotech pay?

Over the past 12 months, Sona Nanotech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sona Nanotech is expected to pay a dividend of 0 CAD.

What is the dividend yield of Sona Nanotech?

The current dividend yield of Sona Nanotech is .

When does Sona Nanotech pay dividends?

Sona Nanotech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Sona Nanotech?

Sona Nanotech paid dividends every year for the past 0 years.

What is the dividend of Sona Nanotech?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Sona Nanotech located?

Sona Nanotech is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sona Nanotech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sona Nanotech from 11/8/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.

When did Sona Nanotech pay the last dividend?

The last dividend was paid out on 11/8/2024.

What was the dividend of Sona Nanotech in the year 2023?

In the year 2023, Sona Nanotech distributed 0 CAD as dividends.

In which currency does Sona Nanotech pay out the dividend?

The dividends of Sona Nanotech are distributed in CAD.